Organization (Nonprofit)
European Society of Cardiology
ClinicalTrials.gov lists European Society of Cardiology as lead sponsor of 12 trials, counting the companies grouped under it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. Companies grouped under this one are not included. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 2 registered with a 2026 start date. The dashed outline is the pace from the 2 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 1.4 trial starts a year over the five years to September, under the 5 a year the method needs.
Logo ESC Organisation, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.
This page covers European Society of Cardiology and 1 company grouped under it: 12 lead-sponsored trials (9 its own, 3 in the grouped companies) and 2 legal-entity registrations (1 its own, 1 in the grouped companies).
Companies grouped under this page (1)
| Company | Country | Lead trials | Legal entities |
|---|---|---|---|
| Société Française de Cardiologie | FR | 3 | 1 |
Disease areas (26)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Atrial Fibrillation | 4 |
| Coronary Disease | 2 |
| Acute Coronary Syndrome | 1 |
| Angina Pectoris | 1 |
| Angina, Unstable | 1 |
Showing 5 of 26 disease areas.
Trials by start year as sponsor or collaborator (9)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2025 | 1 |
| 2024 | 3 |
| 2021 | 2 |
| 2020 | 1 |
| 2018 | 1 |
| 2016 | 2 |
| 2014 | 1 |
| 2013 | 1 |
Recruitment duration, a model prediction: none of the 9 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 1 of 2 hit target (n=2) | 0 of 4 on time (n=4) |
Journals published in (13)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Advances in pharmacology (San Diego, Calif.) | 1 |
| BMJ open | 1 |
| Cardiovascular diabetology | 1 |
| Circulation | 1 |
| Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology | 1 |
Showing 5 of 13 journals.
Organization relationships (12)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Leipzig University | Co sponsors trial with | 1 |
| Harris Health System | Co sponsors trial with | 1 |
| Universidad de Granada | Co sponsors trial with | 1 |
| Regional Hospital West Jutland | Co sponsors trial with | 1 |
| European Clinical Research Infrastructure Network | Co sponsors trial with | 1 |
Showing 5 of 12 relationships.
Latest dated events (14)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-08-28 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-04-23 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2025-08-29 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2024-12-02 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2024-09-27 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 14 events.
Biomarker capability evidence (2)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| PDE5A | Trial collaborator | Named in trial exclusion criteria |
| PDE5A | Trial collaborator | Mentioned in trial text |
Not on this page
Checked, with nothing recorded for this organization: related companies not grouped here, active development programs, approved assets, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarkers this organization publishes on.